Status:
RECRUITING
CYSTEA-BONE Clinical Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Nephropathic Cystinosis
Eligibility:
All Genders
2+ years
Brief Summary
Nephropathic Cystinosis (NC) is an orphan inherited autosomal recessive disease characterised as a generalized lysosomal storage disease due to a deficiency of the cystine lysosomal transport protein,...
Eligibility Criteria
Inclusion Criteria:
- Male and female subjects with confirmed diagnosis of nephropathic cystinosis (defined by clinical signs, White Blood Cells (WBC) cystine level and/or mutation), currently receiving oral cysteamine.
- Age > 2 years.
- Subjects and/or their parents/ legal guardian must provide non opposition prior to participation in the study.
Exclusion Criteria:
- Subjects who, in the opinion of the Investigator, are not able or willing to comply with the protocol.
Key Trial Info
Start Date :
April 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 5 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03919981
Start Date
April 5 2019
End Date
October 5 2026
Last Update
March 3 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France, 25030
2
CHU Bordeaux - Hôpital Pellegrin tripode
Bordeaux, France, 33000
3
Hôpital Femme Mère Enfant
Bron, France, 69677
4
Hôpital Jeanne de Flandre
Lille, France, 59037